ECONOMIC BURDEN OF MYELODYSPLASTIC SYNDROMES AMONG US MEDICARE BENEFICIARIES: INCREASED COSTS IN TRANSFUSION DEPENDENT PATIENTS

被引:0
|
作者
Goldberg, S. L. [1 ]
Chen, E. [4 ]
Corral, M. [2 ]
Guo, A. [3 ]
Laouri, M. [4 ]
机构
[1] John Theurer Canc Ctr, Hackensack, NJ USA
[2] Novartis, Oncol, E Hanover, NJ USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Quorum Consulting Inc, San Francisco, CA USA
关键词
D O I
10.1016/S1098-3015(10)72124-0
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A29 / A29
页数:1
相关论文
共 50 条
  • [31] MORTALITY BURDEN OF TRANSFUSION DEPENDENCY AND IRON OVERLOAD IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.
    Arnan, M.
    Pomares, H.
    Esteban, L.
    Alonso, E.
    Pareja, L.
    Sanchez-Ortega, I.
    Fernandez de Sevilla, A.
    Ribes, J.
    Duarte, R.
    HAEMATOLOGICA, 2013, 98 : 86 - 86
  • [32] Arrhythmia Burden and Associated Outcomes Among Patients With Myelodysplastic Syndromes
    Oyenubi, Olamide
    Momoh, Omolegho
    Hirst, Priscila
    Benjamin, Patrick
    Pomerantz, Daniel
    Chan, Marvyn Allen G.
    Jesmajian, Stephen
    CIRCULATION, 2022, 146
  • [33] Reduced mortality, complications, and economic burden among medicare beneficiaries receiving influenza antivirals
    Best, Jennie H.
    Reddy, Sheila R.
    Chang, Eunice
    Bognar, Katalin
    Tarbox, Marian H.
    Cagas, Steven E.
    Seetasith, Arpamas
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 240 - 252
  • [34] Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries
    Liu, J.
    Gong, T.
    Xu, X.
    Fox, K. M.
    Oates, M.
    Gandra, S. R.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (02) : 413 - 423
  • [35] Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries
    J. Liu
    T. Gong
    X. Xu
    K.M. Fox
    M. Oates
    S.R. Gandra
    Osteoporosis International, 2022, 33 : 413 - 423
  • [36] Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes
    Roy, Noemi B. A.
    Myerson, Saul
    Schuh, Anna H.
    Bignell, Patricia
    Patel, Roger
    Wainscoat, Jim S.
    McGowan, Simon
    Marchi, Emanuele
    Atoyebi, Wale
    Littlewood, Tim
    Chacko, Joseph
    Vyas, Paresh
    Killick, Sally B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (04) : 521 - 524
  • [37] Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
    Jansen, AJG
    Essink-Bot, ML
    Beckers, EAM
    Hop, WCJ
    Schipperus, MR
    van Rhenen, DJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 270 - 274
  • [38] Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage
    Cisternas, Miriam G.
    Foreman, Aimee J.
    Marshall, Thomas S.
    Runken, M. Chris
    Kobashi, Kathleen C.
    Seifeldin, Raafat
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 911 - 919
  • [39] Cost of transfusion dependency among managed care patients with myelodysplastic syndromes
    Frytak, J. R.
    Henk, H. J.
    de Castro, C. M.
    Halpern, R.
    Nelson, M.
    LEUKEMIA RESEARCH, 2007, 31 : S111 - S112
  • [40] Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines
    Davidoff, Amy J.
    Weiss, Sheila R.
    Baer, Maria R.
    Ke, Xuehua
    Hendrick, Franklin
    Zeidan, Amer
    Gore, Steven D.
    LEUKEMIA RESEARCH, 2013, 37 (06) : 675 - 680